Aurora, Colorado
United States
7
2020-05-28
7
2022-04-12
These are the the leading inventors for applications assigned to MBC Pharma, Inc.:
MBC Pharma, Inc. based in Aurora, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Ibandronate conjugates of nucleoside antimetabolites
#2 | 2019-11-21 ✅ Patent 11,324,767 granted on 2022-05-10Drug combination treatments using bone-targeting therapeutics for bone and bone-related disease
#3 | 2016-04-07 ✅ Patent 10,046,055 granted on 2018-08-14Bone targeted therapeutics and methods of making and using the same
#4 | 2014-11-06 ✅ Patent 9,334,300 granted on 2016-05-10Vitamin B6 derivatives of nucleotides, acyclonucleotides and acyclonucleoside phosphonates
#5 | 2014-02-20 ✅ Patent 9,216,204 granted on 2015-12-22Bone targeted therapeutics and methods of making and using the same
#6 | 2009-09-10 ✅ Patent 8,586,781 granted on 2013-11-19Bone targeted therapeutics and methods of making and using the same
#7 | 2005-02-03 ✅ Patent 7,598,246 granted on 2009-10-06Bisphosphonate conjugates and methods of making and using the same
Also check out MBC Pharma, Inc.'s (Aurora, United States) applicant profile with 4 patent applications submitted.
55828 ⎘